TABLE 3.
Means, SDs, ANOVA result, and effect size for the outcome measures at pretreatment, after they had received both treatments, and at 3-month follow-up (including all participants who endorsed at least some level [greater than 0] of the outcome variable at pretreatment)
| Overcome Variable | N | Pretreatment Mean (SD) | After Both Treatments Mean (SD) | 3-Month Follow-up Mean (SD) | P value for Time Effect | Effect Size (η2PARC) for Time Effect |
|---|---|---|---|---|---|---|
| Primary outcome measures | ||||||
| Average pain | 22 | 2.86a (1.21) | 1.64b (1.26) | 1.86b (1.39) | .001 | 0.29 |
| Intensity (NRS-11) | 29 | 54.87a (6.54) | 48.52b (7.72) | 48.53b (9.10) | <.000 | 0.28 |
| Fatigue (PROMIS) | ||||||
| Sleep problems (MOS) | 29 | 46.65a (17.06) | 28.43b (14.13) | 27.99b (16.28) | <.000 | 0.41 |
| Secondary outcome measures | ||||||
| Depression (PHQ-8) | 29 | 6.38a (3.11) | 3.17b (2.67) | 3.41b (2.37) | <.000 | 0.33 |
| Pain interference (PROMIS) | 29 | 51.78a (8.24) | 49.60a (6.75) | 49.47a (7.51) | .168 | 0.06 |
| Pain Catastrophizing (PCS) | 20 | 13.05a (9.88) | 3.95b (3.78) | 3.70b (4.60) | <.000 | 0.39 |
| Cancer treatment distress (CTXD) | 29 | 0.94a (0.50) | 0.51b (0.43) | 0.57b (0.45) | <.000 | 0.37 |
Means with different subscripts are significantly different from one another (P < .05, Bonferroni adjusted).
*
P value for repeated measures ANOVA group by time interaction (P < .05, Bonferroni adjusted).